Latest Psoriasis Stories
Researchmoz presents this most up-to-date research on "Psoriasis and Hepatitis C Pipeline Review, H1 2014".
DUBLIN, April 9, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/stldww/global_psoriasis) has announced the addition of the "Global
FLINT, Mich., April 4, 2014 /PRNewswire-iReach/ -- Diplomat has announced that it is one of a select group of specialty pharmacies contracted by Celgene to distribute Otezla® (apremilast),
Results from Phase 2b X-PLORE Study through Week 40 Report Efficacy of Guselkumab across Multiple Dosing Regimens and Compared with Adalimumab DENVER, March 24, 2014 /PRNewswire/ -- New findings
- FEATURE and JUNCTURE data show secukinumab delivered significant skin clearance at week 12(1,2) EAST HANOVER, N.J., March 22, 2014 /PRNewswire/ -- Novartis today announced results
CANTERBURY, England, March 21, 2014 /PRNewswire/ -- - Phase 2b data demonstrates a 60% reduction in pruritus in psoriatic patients treated with
NORTH CHICAGO, Ill., March 20, 2014 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the initiation of a pivotal Phase 3 clinical trial that will evaluate the use of HUMIRA® (adalimumab) as a treatment
Psoriasis Free For Life made by Katy Wilson is a newly updated psoriasis treatment program includes natural and safe remedies for reducing symptoms of psoriasis disease.
Cloud-based training collaboration delivers clinically relevant information anywhere. CONSHOHOCKEN, Pa., March 18, 2014 /PRNewswire/ -- The Group for Research and Assessment of
- A political dynamiter.